Somewhat Positive Media Coverage Somewhat Unlikely to Impact IMS Health (NYSE:IMS) Stock Price

Press coverage about IMS Health (NYSE:IMS) has trended somewhat positive this week, Accern Sentiment Analysis reports. Accern identifies negative and positive media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. IMS Health earned a media sentiment score of 0.22 on Accern’s scale. Accern also assigned news articles about the information technology services provider an impact score of 42.7991220466626 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

The firm has a market cap of $10,330.00 and a price-to-earnings ratio of 74.62. IMS Health has a 12-month low of $22.36 and a 12-month high of $31.59. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 2.53.

WARNING: “Somewhat Positive Media Coverage Somewhat Unlikely to Impact IMS Health (NYSE:IMS) Stock Price” was first posted by The Lincolnian Online and is owned by of The Lincolnian Online. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.thelincolnianonline.com/2018/01/14/somewhat-favorable-media-coverage-somewhat-unlikely-to-affect-ims-health-ims-share-price-updated.html.

About IMS Health

IMS Health Holdings, Inc (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company’s data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community.

Insider Buying and Selling by Quarter for IMS Health (NYSE:IMS)

Receive News & Ratings for IMS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply